Levalbuterol HCL Solution
SOL #: SPE2D221R0116Solicitation
Overview
Buyer
DEPT OF DEFENSE
Defense Logistics Agency
DLA TROOP SUPPORT
PHILADELPHIA, PA, 19111, United States
Place of Performance
Place of performance not available
NAICS
Pharmaceutical Preparation Manufacturing (325412)
PSC
Drugs And Biologicals (6505)
Set Aside
No set aside specified
Original Source
Timeline
1
Posted
Sep 30, 2021
2
Last Updated
Aug 5, 2025
3
Submission Deadline
Mar 21, 2022, 7:00 PM
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Amendment 0002 is issued to extend the closing date from March 07, 2022 to March 21, 2022 3:00 PM EDT (Eastern Daylight Time)
Amendment 0001 issued to solicitation for SPE2D2-21-R-0116 Levalbuterol HCL Solution to add (MG) Milligrams to the unit item description.
SPE2D2-21-R-0116 Levalbuterol HCL Solution Solicitation
People
Points of Contact
Phyllis DaraioPRIMARY
Files
Versions
Version 12
Solicitation
Posted: Aug 5, 2025
Version 11
Solicitation
Posted: Aug 1, 2024
Version 10
Award Notice
Posted: Aug 23, 2023
Version 9
Award Notice
Posted: Jul 31, 2023
Version 8
Award Notice
Posted: Aug 31, 2022
Version 7
Solicitation
Posted: Apr 1, 2022
Version 6
Solicitation
Posted: Mar 14, 2022
Version 5
Solicitation
Posted: Mar 3, 2022
Version 4Viewing
Solicitation
Posted: Feb 25, 2022
Version 3
Solicitation
Posted: Feb 7, 2022
Version 2
Solicitation
Posted: Feb 3, 2022
Version 1
Pre-Solicitation
Posted: Sep 30, 2021